Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colony stimulating factor 1 (CSF1), also known as macrophage colony-stimulating factor (M-CSF), is a secreted cytokine that plays a central role in the regulation of survival, proliferation, differentiation, and function of mononuclear phagocytes—primarily macrophages and their progenitors. It exerts its biological effects by binding to the high-affinity cell-surface tyrosine kinase receptor CSF-1R. Targeting the CSF1/CSF1R axis has become an area for therapeutic intervention, particularly in oncology settings, due to its role in modulating tumor-associated macrophages.
Inhibition of CSF1 signaling, either by directly targeting the CSF1 ligand or the CSF1R receptor.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colony Stimulating Factor 1 (CSF1).